ZYGEL - Trademark Details
Status: 732 - Third Extension - Granted
Image for trademark with serial number 88291596
Serial Number
88291596
Word Mark
ZYGEL
Status
732 - Third Extension - Granted
Status Date
2022-02-04
Filing Date
2019-02-06
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
011518, 261114, 261116, 261121 - More than one drop including teardrops or raindrops. Three or more rectangles. Rectangles touching or intersecting. Rectangles that are completely or partially shaded.
Published for Opposition Date
2020-06-16
Attorney Name
Sarah Anne Keefe
Law Office Assigned Location Code
L20
Employee Name
SMIGA, HOWARD
Statements
Indication of Colors claimed
The color(s) purple, yellow, orange and red is/are claimed as a feature of the mark.
Description of Mark
The mark consists of the word "ZYGEL" in purple stylized text to the left of an arrangement of vertical and horizontal, yellow and orange rectangles with rounded ends featuring three purple teardrop shapes and two red teardrop shapes within a grid pattern created by the rectangles.
Goods and Services
Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders and all of the foregoing solely derived from manufactured synthetic cannabidiol and which do not contain delta-9 tetrahydrocannabinol (THC)
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-02-28
Primary Code
005
Current Trademark Owners
Party Name
Zynerba Pharmaceuticals, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Zynerba Pharmaceuticals, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Zynerba Pharmaceuticals, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Sarah Anne Keefe
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2019-02-09NEW APPLICATION ENTERED IN TRAM
2019-02-28NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-03-21NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-04-05TEAS VOLUNTARY AMENDMENT RECEIVED
2019-04-09ASSIGNED TO LIE
2019-04-17PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
2019-04-18ASSIGNED TO EXAMINER
2019-04-18ASSIGNED TO EXAMINER
2019-09-16ASSIGNED TO EXAMINER
2019-09-17NON-FINAL ACTION WRITTEN
2019-09-17NON-FINAL ACTION E-MAILED
2019-09-17NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-03-11TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-03-11CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-03-12TEAS/EMAIL CORRESPONDENCE ENTERED
2020-05-06EXAMINERS AMENDMENT -WRITTEN
2020-05-06EXAMINERS AMENDMENT E-MAILED
2020-05-06NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2020-05-06EXAMINER'S AMENDMENT ENTERED
2020-05-06APPROVED FOR PUB - PRINCIPAL REGISTER
2020-05-27NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-06-16PUBLISHED FOR OPPOSITION
2020-06-16OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-08-11NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-01-26TEAS EXTENSION RECEIVED
2021-01-26EXTENSION 1 FILED
2021-01-26EXTENSION 1 GRANTED
2021-01-28NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-07-09TEAS EXTENSION RECEIVED
2021-07-09EXTENSION 2 FILED
2021-07-09EXTENSION 2 GRANTED
2021-07-13NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2022-02-04TEAS EXTENSION RECEIVED
2022-02-04EXTENSION 3 FILED
2022-02-04EXTENSION 3 GRANTED
2022-02-08NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED